<DOC>
	<DOCNO>NCT03102229</DOCNO>
	<brief_summary>This study aim demonstrate implementation rapid , multidisciplinary supportive care program patient receive chemoradiotherapy deem high risk hospitalization base real-time pedometer data reduce rate hospitalization chemoradiotherapy within four week radiotherapy completion .</brief_summary>
	<brief_title>Real-time Activity Monitoring Prevent Admissions During RadioTherapy</brief_title>
	<detailed_description>Primary Objective - To demonstrate implementation rapid , multidisciplinary supportive care program patient receive chemoradiotherapy deem high risk hospitalization base real-time pedometer data reduce rate hospitalization chemoradiotherapy within four week radiotherapy completion . Secondary Objectives - To demonstrate feasibility program rapid , multidisciplinary supportive care trigger real-time pedometer data . - To characterize intervention enact multidisciplinary supportive care team . - To explore intervention enact multidisciplinary team patient low recent step count lead increase step count subsequent week compare historical control . - To collect biospecimens future correlative study examine association blood/urine biomarkers patient activity level .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Age &gt; 18 ECOG performance status 02 Able ambulate independently ( without assistance cane walker ) Diagnosis invasive malignancy head neck region , lung , esophagus , stomach Planned treatment fractionate ( â‰¥15 treatment ) external beam radiotherapy concurrent chemotherapy ( cetuximab ) curative intent ( include preoperative postoperative treatment ) Women childbearing potential must : Have negative serum urine pregnancy test within 72 hour prior start study therapy Agree utilize adequate method contraception throughout treatment least 4 week study therapy complete Be advise importance avoid pregnancy trial participation potential risk unintentional pregnancy All patient must sign study specific informed consent prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Activity Monitoring</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>